There's a whole new approach to vascular access device securement. Peripheral intravenous catheter insertion is the most common invasive hospital procedure performed worldwide, but it's extremely prone to complications, with an overall failure rate that has been estimated at 43%. Similarly, millions of central venous catheters are placed every year with prospective studies showing a removal rate due to complications of 8%.
But with SecurePortIV™, all that is changing. SecurePortIV™ is the first and only cyanoacrylate adhesive that is FDA-cleared for securement of vascular access devices. Simpler, stronger and safer, it provides big benefits and advantages over traditional methods of securement.